Skip to main content

PRELUDE CAPITAL MANAGEMENT, LLC

Position in BSX — Boston Scientific Corp

CIK 1387508 NEW YORK, NY

Position in BSX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$329,625
-$316,848 QoQ
Shares Held
5,253
-22.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
12 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in BSX Over Time

Shares Held

Position Value (USD)

Derivatives in BSX

reported options exposure · as of Jun 30, 2020
CallValue
$0
CallShares
0
PutValue
$1,404,400
PutShares
40,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $24,376,191 across 19 Medical Devices names. BSX ranks #8 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 BSX
Boston Scientific Corp
This page
5,253 $329,625

All Filings in BSX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $329,625 5,253
2025-12-31 $646,473 6,780
2025-09-30 $4,062,384 41,610
2025-03-31 $779,903 7,731
2024-12-31 $1,142,492 12,791
2024-06-30 $335,532 4,357
2022-12-31 $966,163 20,881
2021-06-30 $1,503,056 35,151
2020-12-31 $891,380 24,795
2020-09-30 $661,262 17,306
2020-06-30 $1,404,400 40,000
2020-06-30 $2,079,881 59,239
2020-03-31 $2,120 65